Collegium Pharmaceutical Inc. (COLL)
NASDAQ · Healthcare
Collegium Pharmaceutical Inc. Shareholder Equity 2016–2025
Collegium Pharmaceutical Inc. annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Collegium Pharmaceutical Inc. shareholder equity as of December 31, 2025: 301.7M, a 31.83% increase year-over-year.
- Collegium Pharmaceutical Inc. shareholder equity for 2025 were 301.7M, a 31.83% increase from 2024.
- Collegium Pharmaceutical Inc. shareholder equity for 2024 were 228.8M, a 17.10% increase from 2023.
- Collegium Pharmaceutical Inc. shareholder equity for 2023 were 195.4M, a 0.30% increase from 2022.
- Collegium Pharmaceutical Inc. shareholder equity for 2022 were 194.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Collegium Pharmaceutical Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $302 |
| 2024 | $229 |
| 2023 | $195 |
| 2022 | $195 |
| 2021 | $203 |
| 2020 | $186 |
| 2019 | $87 |
| 2018 | $92 |
| 2017 | $104 |
| 2016 | $135 |
Collegium Pharmaceutical Inc. Shareholder Equity — FAQ
Collegium Pharmaceutical Inc. (COLL) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COLL's shareholder equity history?
The chart and table above show Collegium Pharmaceutical Inc.'s shareholder equity by year and by quarter, including the growth rate.